Skip to content

Investigator

David Ouyang

KAISER FOUNDATION RESEARCH INSTITUTE · funded by NHLBI

Companies
2

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$3.3M

Summed across those awards.

First award
May 1, 2024

Latest May 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress

    $700k

    May 1, 2025NHLBIKAISER FOUNDATION RESEARCH INSTITUTENIH RePORTER · 11302361 (opens the source filing in a new tab)

  2. R01

    Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress

    $721k

    May 1, 2025NHLBIKAISER FOUNDATION RESEARCH INSTITUTENIH RePORTER · 11247509 (opens the source filing in a new tab)

  3. R00

    Deep Learning Assessment of the Right Ventricle: Function, Etiology, and Prognosis

    $249k

    Apr 15, 2025NHLBIKAISER FOUNDATION RESEARCH INSTITUTENIH RePORTER · 11292559 (opens the source filing in a new tab)

  4. R01

    Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease

    $834k

    May 1, 2024NHLBICEDARS-SINAI MEDICAL CENTERNIH RePORTER · 11064070 (opens the source filing in a new tab)

  5. R01

    Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease

    $817k

    May 1, 2024NHLBICEDARS-SINAI MEDICAL CENTERNIH RePORTER · 11325063 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources